#17 – Sektor: Helse og livsvitenskap

Unotert

Content provided by Ellen Amalie Vold and Norsk Venturekapitalforening. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ellen Amalie Vold and Norsk Venturekapitalforening or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

2+ y ago 26:59

MP3•Episode home

Archived series ("Inactive feed" status)

When? This feed was archived on October 13, 2022 21:37 (1+ y ago). Last successful fetch was on August 31, 2022 14:28 (1+ y ago)

Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Helse og life science har hatt en formidabel vekst de siste årene, naturlig nok på grunn av korona, men også av andre grunner. Det forteller Ingrid Teigland Akay i Hadean Ventures og Erlend Skagseth i Sarsia Seed mer om i denne episoden.

Our GDPR privacy policy was updated on August 8, 2022. Visit acast.com/privacy for more information.

29 episodes

#Virksomhet #Utdanning #Ellen Amalie Vold #Norsk Venturekapitalforening #Private Equity #Venture Capital